Unverified50% confidenceFactExact time
In-silico antibody optimization refers to designing and screening antibody sequences in a computer-simulated environment rather than synthesizing and testing them one by one in wet-lab experiments; a typical pipeline includes defining the mutation space, using a predictive model as the oracle for scoring, and having an optimization algorithm search for high-scoring variants.
1
Sources
50%
Confidence
Long-term
Relevance
11/2/2026
First Seen
Sources
Related Entities
Related Claims
UnverifiedAntigen screening for personalized cancer vaccines requires an AI-driven algorithm pipeline, including whole-exome sequencing, HLA binding prediction, proteasomal processing prediction, and multiple other steps, ultimately selecting 20–34 neoantigens from hundreds of candidate mutations.66% similarUnverifiedFrontier AI systems have surpassed expert baselines on benchmarks such as in-silico computation and screening-evasion.65% similarUnverifiedCombining AI predictions with experimental perturbations (such as CRISPR screening) is the key path to validating their biological significance.64% similarUnverifiedAI-generated hypotheses are suitable as a candidate list to be screened, requiring layer-by-layer filtering through literature checks, pathway database comparisons, and preliminary experiments.63% similarUnverifiedArtificial Analysis evaluates models across multiple dimensions in a unified, controlled testing environment, and its composite score aggregates reasoning, mathematics, code, knowledge Q&A, and other dimensions through a weighted algorithm.62% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1125208API
curl https://kongchang.com/api/v1/knowledge/claims/1125208MCP
get_claim(id=1125208)